Philipp Blanke, MD, a Jonathan R. Weir-McCall, MBCHB, PHD, b Stephan Achenbach, MD,
c Victoria Delgado, MD, PHD, d Jörg Hausleiter, MD, e Hasan Jilaihawi, MD, f Mohamed …

Transcatheter aortic valve replacement (TAVR) has become a well-accepted option for
treating patients with aortic stenosis at intermediate to high or prohibitive surgical risk. TAVR …

Abstract 3D-printed models fabricated from CT, MRI, or echocardiography data provide the
advantage of haptic feedback, direct manipulation, and enhanced understanding of …

Objectives The authors sought to prospectively determine the safety and efficacy of next-day
discharge using the Vancouver 3M (Multidisciplinary, Multimodality, but Minimalist) Clinical …

Objectives: This study sought to develop a robust and definitive risk model for new
permanent pacemaker implantation (PPMI) after SAPIEN 3 (third generation balloon …

Objectives: The aim of this study was to identify predictors of permanent pacemaker
implantation (PPMI) following transcatheter aortic valve replacement (TAVR) with a balloon …

Background: Bioprosthetic aortic valve degeneration is increasingly common, often
unheralded, and can have catastrophic consequences. Objectives: The authors sought to …

Atrial fibrillation (AF) is a common arrhythmia in patients with aortic stenosis. When these
patients are treated medically or by surgical aortic valve replacement, AF is associated with …

Conventional tissue engineering, cell therapy, and current medical approaches were shown
to be successful in reducing mortality rate and complications caused by cardiovascular …

Background: Major uncertainties remain regarding disease activity within the retained native
aortic valve, and regarding bioprosthetic valve durability, after transcatheter aortic valve …